Literature DB >> 16330432

Expression of alternative transcripts of ferroportin-1 during human erythroid differentiation.

Luciano Cianetti1, Patrizia Segnalini, Alessia Calzolari, Ornella Morsilli, Federica Felicetti, Carlo Ramoni, Marco Gabbianelli, Ugo Testa, Nadia Maria Sposi.   

Abstract

BACKGROUND AND OBJECTIVES: Ferroportin-1 (FPN1) is expressed in various types of cells that play critical roles in mammalian iron metabolism and appears to act as an iron exporter in these tissues. The aim of this study was to investigate whether erythroid cells possess specific mechanisms for iron export. DESIGN AND METHODS: The expression of FPN1 during human erythroid differentiation, the characterization of alternative transcripts, the modulation by iron and the subcellular localization of this protein were studied.
RESULTS: FPN1 mRNA and protein are highly expressed during human erythroid differentiation. The iron-responsive element (IRE) in the 5'- untranslated region (UTR) of FPN1 mRNA is functional but, in spite of that, FPN1 protein expression, as well as mRNA level and half-life, seem not to be affected by iron. To explain these apparenthy discordant results we searched for alternative transcripts of FPN1 and found at least three different types of transcripts, displaying alternative 5' ends. Most of the FPN1 transcripts code for the canonical protein, but only half of them contain an IRE in the 5'-UTR and have the potential to be translationally regulated by iron. Expression analysis shows that alternative FPN1 transcripts are differentially expressed during erythroid differentiation. Finally, sustained expression of alternative FPN1 transcripts is apparently observed only in erythroid cells. INTERPRETATION AND
CONCLUSIONS: This is the first report describing the presence of FPN1 in erythroid cells at all stages of differentiation, providing evidence that erythroid cells possess specific mechanisms of iron export. The existence of multiple FPN1 transcripts indicates a complex regulation of the FPN1 gene in erythroid cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16330432

Source DB:  PubMed          Journal:  Haematologica        ISSN: 0390-6078            Impact factor:   9.941


  21 in total

1.  Ferroportin deficiency in erythroid cells causes serum iron deficiency and promotes hemolysis due to oxidative stress.

Authors:  De-Liang Zhang; Manik C Ghosh; Hayden Ollivierre; Yan Li; Tracey A Rouault
Journal:  Blood       Date:  2018-09-13       Impact factor: 22.113

2.  Differing expression of genes involved in non-transferrin iron transport across plasma membrane in various cell types under iron deficiency and excess.

Authors:  Kamila Balusikova; Jitka Neubauerova; Marketa Dostalikova-Cimburova; Jiri Horak; Jan Kovar
Journal:  Mol Cell Biochem       Date:  2008-10-02       Impact factor: 3.396

Review 3.  The long history of iron in the Universe and in health and disease.

Authors:  Alex D Sheftel; Anne B Mason; Prem Ponka
Journal:  Biochim Biophys Acta       Date:  2011-08-09

Review 4.  Nutrient transport in the mammary gland: calcium, trace minerals and water soluble vitamins.

Authors:  Nicolas Montalbetti; Marianela G Dalghi; Christiane Albrecht; Matthias A Hediger
Journal:  J Mammary Gland Biol Neoplasia       Date:  2014-02-25       Impact factor: 2.673

Review 5.  Function of alternative splicing.

Authors:  Olga Kelemen; Paolo Convertini; Zhaiyi Zhang; Yuan Wen; Manli Shen; Marina Falaleeva; Stefan Stamm
Journal:  Gene       Date:  2012-08-15       Impact factor: 3.688

6.  Hepcidin regulates ferroportin expression and intracellular iron homeostasis of erythroblasts.

Authors:  De-Liang Zhang; Thomas Senecal; Manik C Ghosh; Hayden Ollivierre-Wilson; Tiffany Tu; Tracey A Rouault
Journal:  Blood       Date:  2011-06-23       Impact factor: 22.113

7.  Ferroportin and erythroid cells: an update.

Authors:  Luciano Cianetti; Marco Gabbianelli; Nadia Maria Sposi
Journal:  Adv Hematol       Date:  2010-08-11

Review 8.  Anaemia in kidney disease: harnessing hypoxia responses for therapy.

Authors:  Mark J Koury; Volker H Haase
Journal:  Nat Rev Nephrol       Date:  2015-06-09       Impact factor: 28.314

Review 9.  Physiology and pathophysiology of iron in hemoglobin-associated diseases.

Authors:  Thomas D Coates
Journal:  Free Radic Biol Med       Date:  2014-04-12       Impact factor: 7.376

Review 10.  Iron-regulatory proteins: molecular biology and pathophysiological implications.

Authors:  Gaetano Cairo; Stefania Recalcati
Journal:  Expert Rev Mol Med       Date:  2007-12-05       Impact factor: 5.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.